DR. LAURA C. DICKERSON MD NPI 1417031238

NPI Details

DR. Laura C. Dickerson, MD is a medical oncology internal medicine in Gainesville, FL with 25 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Laura C. Dickerson, MD NPI is 1417031238. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

6420 W NEWBERRY RD
EAST WING, SUITE 100
GAINESVILLE, FL
ZIP 32605-308
Phone: (352) 332-3900
Fax: (352) 332-5009

The NPI 1417031238 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Vitamin d-3 level (HCPCS:82306)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Folic acid level, serum (HCPCS:82746)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Magnesium level (HCPCS:83735)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count, automated test (HCPCS:85045)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Red blood count, manual test (HCPCS:85044)
• Haptoglobin (serum protein) level (HCPCS:83010)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Automated urinalysis test (HCPCS:81003)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)

The enumeration date for this NPI number is 10/25/2006 and was last updated on 5/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.